GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Float Percentage Of Total Shares Outstanding

Celadon Pharmaceuticals (LSE:CEL) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 17, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Celadon Pharmaceuticals's float shares is 0.00 Mil. Celadon Pharmaceuticals's total shares outstanding is 65.49 Mil. Celadon Pharmaceuticals's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Celadon Pharmaceuticals's Insider Ownership is 43.49%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Celadon Pharmaceuticals's Institutional Ownership is 0.00%.


Celadon Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Celadon Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/65.49
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Celadon Pharmaceuticals (LSE:CEL) Business Description

Industry
Traded in Other Exchanges
N/A
Address
32-33 Cowcross Street, London, GBR, EC1M 6DF
Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis.

Celadon Pharmaceuticals (LSE:CEL) Headlines

No Headlines